Estradiol diagnostic test kits recalled for falsely elevated results
Siemens Atellica IM Enhanced Estradiol test kits can produce falsely elevated results in plasma specimens, potentially leading to misinterpretation of patient hormone measurements. Approximately 2,044 units worldwide are affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II in vitro diagnostic device recall with potential to produce inaccurate test results that could affect clinical decision-making. Although no illnesses or injuries are reported in the source, the defect presents a risk of patient harm through misinterpretation of critical hormone test measurements.
Plain-English summary
Siemens Healthcare Diagnostics is recalling the Atellica IM Enhanced Estradiol (eE2) 100T diagnostic test kits due to their potential to produce falsely elevated results when testing plasma specimens. This defect could lead clinicians to misinterpret patient results.
The affected test kits were distributed worldwide, including throughout the United States and numerous international markets in Europe, Asia, Africa, and the Middle East. All lot numbers containing the specified UDI codes are included in this recall, with approximately 2,044 units affected.
Healthcare facilities and laboratories currently using these test kits should contact Siemens Healthcare Diagnostics for replacement or return instructions. Facilities should review their procedures and consider the appropriateness of retesting patients whose results were obtained with these kits, as falsely elevated hormone measurements could impact clinical decision-making.
The recalled product
- Product
- Atellica IM Enhanced Estradiol (eE2) 100T - In vitro diagnostic use in the quantitative determination of estradiol SMN: 10995561 All lots
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Hazard
- falsely-elevated-results
- diagnostic-error
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereMedline Spinal Block Kits Recalled for Data Integrity and Efficacy Issues
FDA (Devices) · 2026-06-03
- SevereAbiomed Automated Impella Controller recalled for motor control and pump failure risks
FDA (Devices) · 2026-06-03
- HighGE APEXPRO and CARESCAPE Telemetry Systems Risk Loss of Patient Monitoring
FDA (Devices) · 2026-06-03
- CriticalMedline spinal anesthetic kits recalled for quality and efficacy concerns
FDA (Devices) · 2026-06-03
- SevereMedline spinal anesthesia kits recalled for bupivacaine quality issues
FDA (Devices) · 2026-06-03